Analysts Set Pediatrix Medical Group, Inc. (NYSE:MD) Price Target at $16.67

Pediatrix Medical Group, Inc. (NYSE:MD) has been assigned an average rating of “Hold” from the six brokerages that are covering the company, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $16.67.

Several research analysts have weighed in on the company. Truist Financial cut their price objective on Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating on the stock in a research report on Friday, April 11th. UBS Group cut their price objective on Pediatrix Medical Group from $18.50 to $16.00 and set a “neutral” rating on the stock in a research report on Monday, May 12th. Finally, Macquarie boosted their price objective on Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an “outperform” rating in a research report on Thursday, May 8th.

Institutional Trading of Pediatrix Medical Group

Several hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. raised its stake in shares of Pediatrix Medical Group by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 10,812,611 shares of the company’s stock valued at $141,861,000 after buying an additional 113,976 shares during the period. Boston Partners raised its stake in shares of Pediatrix Medical Group by 1.3% in the first quarter. Boston Partners now owns 1,981,889 shares of the company’s stock valued at $27,990,000 after buying an additional 25,536 shares during the period. Geode Capital Management LLC raised its stake in shares of Pediatrix Medical Group by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 1,947,796 shares of the company’s stock valued at $25,562,000 after buying an additional 11,045 shares during the period. American Century Companies Inc. raised its stake in shares of Pediatrix Medical Group by 628.2% in the fourth quarter. American Century Companies Inc. now owns 1,739,323 shares of the company’s stock valued at $22,820,000 after buying an additional 1,500,485 shares during the period. Finally, Northern Trust Corp raised its stake in shares of Pediatrix Medical Group by 18.0% during the 4th quarter. Northern Trust Corp now owns 966,347 shares of the company’s stock valued at $12,678,000 after purchasing an additional 147,522 shares during the period. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Stock Up 2.3%

Shares of NYSE:MD opened at $13.85 on Friday. The business’s 50 day moving average is $13.67 and its 200 day moving average is $14.02. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group has a 12-month low of $6.62 and a 12-month high of $17.67. The stock has a market cap of $1.19 billion, a price-to-earnings ratio of -11.54, a PEG ratio of 1.74 and a beta of 1.26.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.08. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The business had revenue of $458.36 million for the quarter, compared to analysts’ expectations of $451.44 million. During the same quarter in the previous year, the firm earned $0.20 earnings per share. The business’s revenue was down 7.4% on a year-over-year basis. On average, sell-side analysts forecast that Pediatrix Medical Group will post 1.38 earnings per share for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.